Literature DB >> 19208770

Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy.

Sascha David1, Philipp Kümpers, Georg M Eisenbach, Hermann Haller, Jan T Kielstein.   

Abstract

INTRODUCTION: Under physiological conditions kidneys work continuously, 168 h/week. In contrast, patients with end-stage renal disease are usually dialyzed only 12-15 h/ week. This unphysiological dialysis dose, even if considered adequate by current Kt/V-based dose estimates, is just capable to maintain the alterations of multiple metabolic parameters at a level that permits an unacceptable annual mortality rate of 10-20%, mainly due to cardiovascular events, protein energy wasting and infections. PATIENTS AND METHODS: Thirteen haemodialysis patients were converted from conventional (3 x 4 h/week) to an intensified nocturnal (3 x 8 h/week) dialysis and were longitudinally followed up for 12 months. Different parameters were evaluated before treatment conversion and quarterly during the follow-up period [i.e. dialysis efficacy (eKt/V), mean arterial pressure (MAP), antihypertensive drug score, extra-cellular volume (ECV), haemoglobin, transferrin saturation, ferritin, dose of erythropoiesis-stimulating agents (ESA), iron requirement, parameters of nutrition (body weight (BW), albumin, protein, normalized protein catabolic rate (nPCR), bioelectrical impedance analysis (BIA)), C-reactive protein, calcium-phosphate product, alkaline phosphatase (AP), intact parathyroid hormone (iPTH) and amount of phosphate-binding pharmacotherapy].
RESULTS: The calculated dialysis efficacy rose after switching the treatment mode (eKt/V 1.87 versus 2.7, P < 0.0001). Further, a significantly decreased MAP in the pre- (100 versus 89 mmHg) and postdialytic period (97 versus 83 mmHg), and a decreased ECV (13.8 versus 13.2 L; P = 0.03) even though antihypertensive pharmacotherapy could be substantially reduced (P < 0.0001), was found. Concomitant with a reduction of ESA (66.5 versus 45.2 IU/ kg/week; P = 0.006), the haemoglobin level rose significantly (11.4 versus 12.5 g/dL, P = 0.01). Nutritional status assessed by BW (70.9 +/- 20.2 versus 72.1 +/- 19.8 kg, P = 0.02), nPCR (1.39 versus 2.25 g/kg/day, P = 0.02) and BIA (phase angle: 6.2 versus 6.9 degrees, P < 0.001) improved. The calcium-phosphate product slightly declined, without changes in the dose of any phosphate binders. Surprisingly, iPTH of those patients with intact parathyroid glands (n = 7) increased approximately 3-fold (27.9 versus 59.35 pmol/L, P = 0.009), while the AP was found stable.
CONCLUSION: This study demonstrates improvements in numerous dialysis-associated metabolic variables after intensification of HD time. Of note, an increase of iPTH was detected in those patients with intact parathyroid glands.

Entities:  

Mesh:

Year:  2009        PMID: 19208770     DOI: 10.1093/ndt/gfp029

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  14 in total

1.  Selectively increasing the clearance of protein-bound uremic solutes.

Authors:  Tammy L Sirich; Frank J-G Luo; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  Nephrol Dial Transplant       Date:  2012-01-09       Impact factor: 5.992

2.  Survival with three-times weekly in-center nocturnal versus conventional hemodialysis.

Authors:  Eduardo Lacson; Jianglin Xu; Rita S Suri; Gihad Nesrallah; Robert Lindsay; Amit X Garg; Keith Lester; Norma Ofsthun; Michael Lazarus; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2012-02-23       Impact factor: 10.121

3.  Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis.

Authors:  Paweena Susantitaphong; Ioannis Koulouridis; Ethan M Balk; Nicolaos E Madias; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2012-02-25       Impact factor: 8.860

4.  Reduction of carbamylated albumin by extended hemodialysis.

Authors:  Jeffrey Perl; Sahir Kalim; Ron Wald; Marc B Goldstein; Andrew T Yan; Nazanin Noori; Mercedeh Kiaii; Julia Wenger; Christopher Chan; Ravi I Thadhani; S Ananth Karumanchi; Anders H Berg
Journal:  Hemodial Int       Date:  2016-06-21       Impact factor: 1.812

Review 5.  Nocturnal intermittent hemodialysis.

Authors:  Julia Thumfart; Dominik Müller
Journal:  Pediatr Nephrol       Date:  2014-08-08       Impact factor: 3.714

6.  Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis.

Authors:  Ron Wald; Andrew T Yan; Jeffrey Perl; Depeng Jiang; M Sandra Donnelly; Howard Leong-Poi; Philip A McFarlane; Jordan J Weinstein; Marc B Goldstein
Journal:  BMC Nephrol       Date:  2012-01-19       Impact factor: 2.388

7.  Cost analysis of in-centre nocturnal compared with conventional hemodialysis.

Authors:  Ben Wong; Mark Courtney; Robert P Pauly; Kailash Jindal; Scott Klarenbach
Journal:  Can J Kidney Health Dis       Date:  2014-07-02

8.  The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis.

Authors:  Frank Xiaoqing Liu; Catrin Treharne; Bruce Culleton; Lydia Crowe; Murat Arici
Journal:  BMC Nephrol       Date:  2014-10-02       Impact factor: 2.388

Review 9.  Nutritional Status in Nocturnal Hemodialysis Patients - A Systematic Review with Meta-Analysis.

Authors:  Karin J R Ipema; Simone Struijk; Annet van der Velden; Ralf Westerhuis; Cees P van der Schans; Carlo A J M Gaillard; Wim P Krijnen; Casper F M Franssen
Journal:  PLoS One       Date:  2016-06-20       Impact factor: 3.240

10.  Zinc-alpha2-glycoprotein in patients with acute and chronic kidney disease.

Authors:  Inga Sörensen-Zender; Jan Beneke; Bernhard M W Schmidt; Jan Menne; Hermann Haller; Roland Schmitt
Journal:  BMC Nephrol       Date:  2013-07-12       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.